Patient safety is the utmost importance to you. We understand. It is for us too. Quantitative Neuromuscular Blockade Monitoring augments your clinical expertise and provides unwavering confidence in clinical decision making from start to finish.
Senzime´s innovative device, TetraGraph®, supports the optimization of patient management in patients receiving neuromuscular blocking agents (NMBAs). TetraGraph® can be used from start to finish during the surgical procedure. The quantitative monitor enables objective assessment of the depth of block and titration of medication dosage to help determine when the patient has recovered sufficiently to maintain spontaneous breathing.
Senzime, Inc. is located in Naples, Florida.
Residual Neuromuscular Blockade
Qualitative vs Quantitative Monitoring
The new Gold Standard